{"log_id": 7509497082558281571, "direction": 0, "words_result_num": 53, "words_result": [{"probability": {"variance": 0.000484, "average": 0.989093, "min": 0.912857}, "location": {"width": 256, "top": 157, "height": 28, "left": 107}, "words": "性粒细胞减少症的患者更是如此"}, {"probability": {"variance": 3.4e-05, "average": 0.996941, "min": 0.968514}, "location": {"width": 901, "top": 181, "height": 31, "left": 151}, "words": "一旦出现第一次稀便,患者需开始饮用大量含电解质的饮料并马上开始抗腹泻治疗。这种抗腹泻治疗应由使用本"}, {"probability": {"variance": 0.000266, "average": 0.995776, "min": 0.902809}, "location": {"width": 628, "top": 211, "height": 33, "left": 106}, "words": "品的单位来进行。出院的患者应携带一定数量的药物以便腹泻发生时及时治疗"}, {"probability": {"variance": 0.001117, "average": 0.989642, "min": 0.781454}, "location": {"width": 908, "top": 239, "height": 31, "left": 143}, "words": "另外,当腹泻发生时,患者应及时就诊,目前,推荐的抗腹泻治疗措施为:高剂量的氯苯哌酰胺(2mg/2小时)这"}, {"probability": {"variance": 5e-05, "average": 0.996103, "min": 0.971887}, "location": {"width": 949, "top": 268, "height": 33, "left": 103}, "words": "种治疗需持续到最后一次稀便结束后12小时,中途不得更改剂量,本药有导致麻痹性肠梗阻的危险。故所有患者以此"}, {"probability": {"variance": 2.7e-05, "average": 0.997108, "min": 0.971647}, "location": {"width": 947, "top": 297, "height": 33, "left": 106}, "words": "剂量用药一方面不得少于12小时,但也不得连续使用超过48小时。除抗腹泻治疗外,当腹泻合并严重的中性粒细胞减"}, {"probability": {"variance": 0.000147, "average": 0.99507, "min": 0.942357}, "location": {"width": 511, "top": 327, "height": 31, "left": 116}, "words": "少症(粒细胞计数<500/mm3)时,应用广谱抗菌素预防性治疗"}, {"probability": {"variance": 2e-06, "average": 0.999075, "min": 0.995841}, "location": {"width": 428, "top": 358, "height": 28, "left": 143}, "words": "除抗腹泻治疗外,当出现以下症状时应住院治疗腹泻"}, {"probability": {"variance": 3e-06, "average": 0.999041, "min": 0.994819}, "location": {"width": 148, "top": 390, "height": 23, "left": 144}, "words": "腹泻同时伴有发热"}, {"probability": {"variance": 0.000159, "average": 0.995034, "min": 0.953473}, "location": {"width": 211, "top": 418, "height": 24, "left": 130}, "words": "一严重腹泻(需静脉补液)"}, {"probability": {"variance": 0.003116, "average": 0.980295, "min": 0.748793}, "location": {"width": 434, "top": 444, "height": 29, "left": 143}, "words": "开始高剂量的氯苯哌酰胺治疗48小时后仍有腹泻发生"}, {"probability": {"variance": 5.5e-05, "average": 0.997052, "min": 0.950824}, "location": {"width": 909, "top": 469, "height": 34, "left": 144}, "words": "氯苯哌酰胺不应用于预防性治疗,甚至前一周期出现过迟发性腹泻的患者也不应如此。出现严重腹泻的患者,在下"}, {"probability": {"variance": 3e-06, "average": 0.998067, "min": 0.993414}, "location": {"width": 272, "top": 505, "height": 25, "left": 109}, "words": "个周期用药应减量(见用法用量)"}, {"probability": {"variance": 0.022696, "average": 0.924198, "min": 0.622894}, "location": {"width": 81, "top": 537, "height": 21, "left": 144}, "words": "5.血液学"}, {"probability": {"variance": 2.4e-05, "average": 0.99702, "min": 0.977953}, "location": {"width": 910, "top": 556, "height": 34, "left": 144}, "words": "在本品治疗期间,每周应查全血细胞计数,患者应了解中性粒细胞减少的危险性及发热的意义,发热性中性粒细胞"}, {"probability": {"variance": 0.008745, "average": 0.975407, "min": 0.528336}, "location": {"width": 391, "top": 591, "height": 28, "left": 109}, "words": "减少症(体温超过38℃,中性粒细胞计数<1000"}, {"probability": {"variance": 2.1e-05, "average": 0.996908, "min": 0.984713}, "location": {"width": 325, "top": 589, "height": 24, "left": 547}, "words": "3,应立即住院静脉滴注广谱抗菌素治疗"}, {"probability": {"variance": 5.3e-05, "average": 0.994483, "min": 0.974455}, "location": {"width": 240, "top": 622, "height": 22, "left": 145}, "words": "只有当中性粒细胞计数>1500"}, {"probability": {"variance": 0.000299, "average": 0.993389, "min": 0.900509}, "location": {"width": 599, "top": 618, "height": 23, "left": 450}, "words": "方可恢复使用本品治疗。当患者出现严重无症状的中性粒细胞减少症(<500"}, {"probability": {"variance": 0.003753, "average": 0.987768, "min": 0.527192}, "location": {"width": 917, "top": 643, "height": 32, "left": 131}, "words": "mm3),发热(体温超过38℃)或感染伴中性粒细胞减少(中性粒细胞计数<1000/mm3),应减量(见用法用量部分)"}, {"probability": {"variance": 0.000153, "average": 0.995034, "min": 0.933744}, "location": {"width": 680, "top": 671, "height": 33, "left": 108}, "words": "对出现严重腹泻的患者,因其感染的危险性及血液学毒性会增加,应做全血细胞计数"}, {"probability": {"variance": 0.000272, "average": 0.993773, "min": 0.893611}, "location": {"width": 882, "top": 699, "height": 33, "left": 171}, "words": "治疗前及每周期化疗前均检查肝功能。肝功能不良患者(胆红素在正常值上限的1.0~1.5倍,转氨酶超过正常"}, {"probability": {"variance": 0.000185, "average": 0.993643, "min": 0.935498}, "location": {"width": 943, "top": 728, "height": 33, "left": 109}, "words": "值上限的5倍时)出现严重中性粒细胞减少症及发热性中性粒细胞减少症的危险性很大,应严密监测。本品禁用于胆红"}, {"probability": {"variance": 0.000139, "average": 0.994492, "min": 0.951882}, "location": {"width": 252, "top": 763, "height": 29, "left": 110}, "words": "素超过正常值上限1.5倍的患者"}, {"probability": {"variance": 0.003959, "average": 0.985461, "min": 0.563425}, "location": {"width": 908, "top": 786, "height": 33, "left": 146}, "words": "7.每次用药前应预防性使用止吐药。本药引起恶心、呕吐的报道很常见。呕吐合并迟发性腹泻的患者应尽快住院"}, {"probability": {"variance": 0, "average": 0.999908, "min": 0.999867}, "location": {"width": 37, "top": 825, "height": 21, "left": 111}, "words": "治疗"}, {"probability": {"variance": 0.0001, "average": 0.996134, "min": 0.945454}, "location": {"width": 880, "top": 843, "height": 31, "left": 172}, "words": "若出现急性胆碱能综合征(早发性腹泻及其他不同症状如出汗、腹部痉挛、流泪、瞳孔缩小及流涎),应使用硫"}, {"probability": {"variance": 0.000603, "average": 0.990492, "min": 0.844471}, "location": {"width": 930, "top": 872, "height": 31, "left": 112}, "words": "酸阿托品治疗(0.25mg皮下注射)。对气喘的患者应小心谨慎。对有急性、严重的胆碱能综合征患者,下次使用本品时"}, {"probability": {"variance": 1.1e-05, "average": 0.997893, "min": 0.98793}, "location": {"width": 202, "top": 906, "height": 26, "left": 110}, "words": "应预防性使用硫酸阿托品"}, {"probability": {"variance": 0.000305, "average": 0.991929, "min": 0.916003}, "location": {"width": 823, "top": 925, "height": 36, "left": 174}, "words": "老年人由于各项生理功能的减退机率很大,尤其是肝功能减退,因此对老年患者选择本品剂量时应谨慎"}, {"probability": {"variance": 9.1e-05, "average": 0.996625, "min": 0.952748}, "location": {"width": 409, "top": 960, "height": 28, "left": 147}, "words": "10.治疗期间及治疗结束后3个月应采取避孕措施"}, {"probability": {"variance": 0.002594, "average": 0.978119, "min": 0.78796}, "location": {"width": 277, "top": 989, "height": 28, "left": 149}, "words": "11.对驾驶和操作机器能力的影响"}, {"probability": {"variance": 7.4e-05, "average": 0.996509, "min": 0.958611}, "location": {"width": 910, "top": 1013, "height": 33, "left": 147}, "words": "患者应注意,在使用本品24小时内,有可能出现头晕及视力障碍,因此建议当这些症状出现时请勿驾车或操作机"}, {"probability": {"variance": 0, "average": 0.999916, "min": 0.999916}, "location": {"width": 22, "top": 1051, "height": 22, "left": 111}, "words": "器"}, {"probability": {"variance": 0.001181, "average": 0.985531, "min": 0.87368}, "location": {"width": 209, "top": 1075, "height": 27, "left": 118}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.004338, "average": 0.984059, "min": 0.540501}, "location": {"width": 908, "top": 1097, "height": 33, "left": 148}, "words": "由于本品在免和大鼠实验中发现有胚胎毒性,胎儿毒性及致畸性。因此,妊娠期间不能使用本品。育龄妇女在接受"}, {"probability": {"variance": 5.1e-05, "average": 0.996563, "min": 0.958851}, "location": {"width": 943, "top": 1126, "height": 33, "left": 112}, "words": "本品治疗期间应避免怀孕,且如一旦怀孕应立即通知医生。目前尚无法证实伊立替康是否会从人类乳汁分泌,但因为可"}, {"probability": {"variance": 0.000295, "average": 0.993591, "min": 0.919569}, "location": {"width": 646, "top": 1156, "height": 33, "left": 113}, "words": "能对哺乳婴儿造成的不良反应,在使用本品治疗期间应停止母乳喂养。(见禁忌)。"}, {"probability": {"variance": 3e-06, "average": 0.998553, "min": 0.994657}, "location": {"width": 99, "top": 1193, "height": 22, "left": 119}, "words": "【儿童用药】"}, {"probability": {"variance": 6.6e-05, "average": 0.996691, "min": 0.968776}, "location": {"width": 240, "top": 1221, "height": 24, "left": 149}, "words": "儿童使用安全有效性还未确定"}, {"probability": {"variance": 5e-06, "average": 0.998406, "min": 0.993744}, "location": {"width": 100, "top": 1251, "height": 22, "left": 118}, "words": "【老年用药】"}, {"probability": {"variance": 7.5e-05, "average": 0.995886, "min": 0.962369}, "location": {"width": 875, "top": 1271, "height": 33, "left": 150}, "words": "由于老年患者各项生理功能的减退机率很大,尤其是肝功能的减退,因此老年患者使用本品时剂量选择应慎重"}, {"probability": {"variance": 3.6e-05, "average": 0.995433, "min": 0.983854}, "location": {"width": 136, "top": 1308, "height": 23, "left": 118}, "words": "【药物相互作用】"}, {"probability": {"variance": 4.9e-05, "average": 0.996886, "min": 0.953158}, "location": {"width": 904, "top": 1328, "height": 33, "left": 151}, "words": "目前尚无药物相互作用方面的报道,但伊立替康与神经肌肉阻滞剂之间的相互作用不可忽视,具有抗胆碱酯酶活性"}, {"probability": {"variance": 0.00051, "average": 0.993122, "min": 0.86305}, "location": {"width": 660, "top": 1359, "height": 32, "left": 115}, "words": "的药物可延长琥珀胆碱的神经肌肉阻滞作用,非去极化神经肌肉阻滞剂可能被拮抗"}, {"probability": {"variance": 7e-06, "average": 0.99799, "min": 0.992492}, "location": {"width": 100, "top": 1395, "height": 22, "left": 119}, "words": "【药物过量】"}, {"probability": {"variance": 0.000233, "average": 0.993987, "min": 0.90692}, "location": {"width": 907, "top": 1415, "height": 33, "left": 151}, "words": "目前尚无过量报道。Ⅱ期研究中,在严密观察下剂量曾高达750mg/m2,最显著的不良反应是严重中性粒细胞减"}, {"probability": {"variance": 5.3e-05, "average": 0.995798, "min": 0.968477}, "location": {"width": 640, "top": 1445, "height": 31, "left": 115}, "words": "少症和腹泻。因而,为防使用过量,应在专科医院使用。目前尚无已知的解毒剂"}, {"probability": {"variance": 1e-05, "average": 0.99749, "min": 0.99233}, "location": {"width": 99, "top": 1480, "height": 24, "left": 120}, "words": "【药理毒理】"}, {"probability": {"variance": 1e-06, "average": 0.998171, "min": 0.99648}, "location": {"width": 71, "top": 1510, "height": 22, "left": 153}, "words": "药理作用"}, {"probability": {"variance": 0.001293, "average": 0.989574, "min": 0.748587}, "location": {"width": 907, "top": 1529, "height": 35, "left": 150}, "words": "伊立替康是喜树碱的半合成衍生物。喜树碱可特异性地与拓扑异构酶I结合,后者诱导可逆性单链断裂,从而使"}, {"probability": {"variance": 0.003559, "average": 0.985416, "min": 0.630412}, "location": {"width": 939, "top": 1560, "height": 33, "left": 116}, "words": "DNA双链结构解旋;伊立替康及其活性代谢物SN-38可与拓扑异构酶I-DNA复合物结合,从而阻止断裂单链的再"}, {"probability": {"variance": 0.003365, "average": 0.984374, "min": 0.680644}, "location": {"width": 941, "top": 1589, "height": 31, "left": 115}, "words": "连接。现有研究提示,伊立替康的细胞毒作用归因于DNA合成过程中,复制酶与拓扑异构酶I-DNA一伊立替康(或"}], "language": 3}